ICM
RSKD icon

Invenomic Capital Management’s Riskified RSKD Stock Holding History

Invenomic Capital Management’s Portfolio RSKD Stock Details RSKD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-552,416
Closed -$2.59M – 166
2025
Q3 		$2.59M Sell
552,416
-29,527
-5% -$145K 0.13% 126
2025
Q2 		$2.9M Sell
581,943
-123,831
-18% -$592K 0.16% 123
2025
Q1 		$3.26M Sell
705,774
-175,012
-20% -$882K 0.16% 134
2024
Q4 		$4.17M Buy
880,786
+108,266
+14% +$502K 0.2% 116
2024
Q3 		$3.65M Sell
772,520
-126,799
-14% -$693K 0.2% 113
2024
Q2 		$5.75M Buy
899,319
+136,116
+18% +$770K 0.28% 95
2024
Q1 		$4.13M Buy
763,203
+174,953
+30% +$831K 0.22% 106
2023
Q4 		$2.75M Buy
+588,250
New +$2.41M 0.13% 133

Other funds holding RSKD

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
HP
Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Invenomic Capital Management's RSKD Position: Q4 2025 in Review

Invenomic Capital Management sold out of Riskified (RSKD) in Q4 2025, closing a stake of 552,416 shares — an estimated $2.59M sold.

Invenomic Capital Management first reported a position in RSKD in Q4 2023 and held it in 8 quarters. The position peaked at $5.75M in Q2 2024. 107 funds tracked by Wall St. Rank hold RSKD as of Q4 2025.

  • Invenomic Capital Management reported no remaining Riskified position as of Q4 2025 after selling out during the quarter.
  • Invenomic Capital Management sold 552,416 Riskified shares in Q4 2025, an estimated $2.59M.
  • Invenomic Capital Management first reported a position in Riskified in Q4 2023 and held it in 8 quarters.
  • Invenomic Capital Management's Riskified position peaked at $5.75M in Q2 2024.
  • 107 funds tracked by Wall St. Rank held Riskified as of Q4 2025.

Based on Invenomic Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.